Articles
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and persistent anemia despite C5-inhibitor treatment
- Journal/Conference:
- Journal of Comparative Effectiveness Research
- Author(s):
- Austin Kulasekararaj, Phillip Scheinberg, Maria-Magdalena Balp, Olivier Somenzi, Anggie Wiyani, Josefin Snellman, Sarah Walsh, Katharina Pannagl, Jason Steenkamp, Régis Peffault de Latour
- Publication Date:
- 2026
- Topic/Therapeutic Area:
- Hematology, Rare Disease
- Condition:
- Rare and Orphan Diseases
Clinical and cost impact of Cabazitaxel versus Lutetium-177 vipivotide tetraxetan (Lu-PSMA) for patients with metastatic castration-resistant prostate cancer (mCRPC)
- Journal/Conference:
- ASCO GU 2026
- Author(s):
- Braydon Nault, David Garcia, Heather Cameron, Andrew Revel, Kevin Steele, Kyle Flannery, Pedro Barata
- Publication Date:
- 2026
- Topic/Therapeutic Area:
- Oncology, Urology
- Condition:
- Prostate Cancer
The Burden of Delayed Diabetic Retinopathy Management and Use of Artificial Intelligence-Driven Screening Tools: A Systematic Literature Review
- Journal/Conference:
- Opthamology and Therapy
- Author(s):
- Firas Rahhal, Jun Zhang & Munia Mukherjee
- Publication Date:
- 2026
- Topic/Therapeutic Area:
- Metabolic
- Condition:
- Diabetes/Endocrine/Metabolic Disorders, Eye
Delphi working group. Delphi panel on neuromodulation as a treatment strategy for dry eye disease: Unlocking the potential of natural tear production
- Journal/Conference:
- Ocular Surface
- Author(s):
- Akpek E, Jones L, Nichols KK, Nijm LM, Pflugfelder S
- Publication Date:
- 2026
- Topic/Therapeutic Area:
- Ophthalmology
- Condition:
- Eye
Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy
- Journal/Conference:
- ClinicoEconomics and Outcomes Research
- Author(s):
- Orlaith Ryan, Maurice Clancy, Alanna MacDonald, Laura Pastor, Megan Bourque
- Publication Date:
- 2026
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Cancer
Radiographic Progression-Free Survival as a Surrogate Endpoint for Overall Survival in First-Line ARPi Naïve Metastatic Castration-Resistant Prostate Cancer
- Journal/Conference:
- The Oncologist
- Author(s):
- Elena Castro, Stefanie Paganelli, Di Wang, Anja Haltner, Alexander Niyazov, Jane Chang, Imtiaz A Samjoo, Pedro C Barata
- Publication Date:
- 2026
- Topic/Therapeutic Area:
- Oncology, Urology
- Condition:
- Prostate Cancer
Systematic Review of Prognostic Factors and Treatment Effect Modifiers for Transthyretin Amyloid Cardiomyopathy
- Journal/Conference:
- Value in Health
- Author(s):
- Chris G. Cameron, Jaydeep Das, Sidsel Høier Gamborg Møller, Mary Chappell, Erin Barker
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Cardiovascular
- Condition:
- Transthyretin Amyloid Cardiomyopathy
Interim results from the HER-TEMPO Study: Real-world study of treatment discontinuations and modifications for patients with HER2-low metastatic breast cancer on trastuzumab deruxtecan.
- Journal/Conference:
- San Antonio Breast Cancer Symposium 2025
- Author(s):
- Brezden-Masley C, Qadeer R, Mouhri ZS, Salvo B, Bonar N, Suero B, Shokar S, Nam A
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Breast Cancer
Interim results from the HER-TEMPO Study: Real-world study of treatment discontinuations and modifications for patients with HER2-positive metastatic breast cancer on trastuzumab deruxtecan.
- Journal/Conference:
- San Antonio Breast Cancer Symposium 2025
- Author(s):
- Brezden-Masley C, Qadeer R, Mouhri ZS, Salvo B, Bonar N, Suero B, Shokar S, Nam A
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Breast Cancer
Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry
- Journal/Conference:
- Value in Health
- Author(s):
- Arif Mitha, Allison Wills, Chris Cameron, Victoria Hodgkinson, Susi Vander Wyk
- Publication Date:
- 2025
- Topic/Therapeutic Area:
- Neurology
- Condition:
- Rare and Orphan Diseases